Predicting the sensitivity of platinum-based chemotherapy

This article talks about a prospective cohort study that indicated HRD testing could accurately predict the sensitivity of platinum-based chemotherapy for ovarian cancer patients.

Related Keywords

China ,Chinese , ,Fudan University Shanghai Cancer Centerteam ,Journal Of Ovarian Research ,Cancer Hospital Of Fudan University ,Sponsored Content ,Recombination Deficiency ,Fudan University Shanghai Cancer ,Ovarian Research ,Image Credit ,Cancer Hospital ,Fudan University ,Analysis Curves Grouped ,Content Policy ,News Medical Net ,Platinum Based Chemotherapy ,Ovarian Cancer Patients ,